We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$282M
AUM Growth
+$12.8M
Cap. Flow
+$1.45M
Cap. Flow %
0.51%
Top 10 Hldgs %
44.88%
Holding
102
New
7
Increased
30
Reduced
38
Closed
11
Avg Time Held
9.6 quarters
Top 10 Avg Time Held
5.9 quarters
Top 20 Avg Time Held
8.3 quarters

Top Sells

Rank Stock Value
1
RTEC
Rudolph Technologies Inc
RTEC
+$2.81M
2
ZGNX
Zogenix, Inc.
ZGNX
+$2.51M
3
CDNA icon
CareDx
CDNA
+$1.79M
4
RHT
Red Hat Inc
RHT
+$1.41M
5
FIVN icon
FIVE9
FIVN
+$955K

Sector Composition

Rank Sector Weight
1 Technology 33.55%
2 Industrials 19.6%
3 Healthcare 12.12%
4 Energy 11.61%
5 Consumer Discretionary 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AT icon
76
DELISTED
Atlantic Power Corporation
AT
$125K 0.04%
53,194
-1,548
-3% -$3.8K
2014 Q3
13 quarters
SRNE
77
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$112K 0.04%
29,568
-2,018
-6% -$5.26K
2015 Q2
10 quarters
TXMD icon
78
TherapeuticsMD
TXMD
$22.9M
$105K 0.04%
348
– –
2017 Q3
1 quarter
CBK icon
79
DELISTED
Christopher & Banks Corporation
CBK
$78K 0.03%
61,651
-61,660
-50% -$78K
2013 Q2
18 quarters
HOS icon
80
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$49K 0.02%
15,765
– –
2015 Q2
10 quarters
BELFB icon
81
Bel Fuse Inc Class B
BELFB
$3.25B
– –
-8,684
Closed -$271K –
CCJ icon
82
Cameco
CCJ
$35.7B
– –
-21,195
Closed -$205K –
FLNA icon
83
Filana Therapeutics
FLNA
$35M
– –
-15,568
Closed -$63K –
TTNP icon
84
DELISTED
Titan Pharmaceuticals
TTNP
– –
-10
Closed -$61K –
VNDA icon
85
Vanda Pharmaceuticals
VNDA
$258M
– –
-18,131
Closed -$325K –
XPRO icon
86
Expro Ltd
XPRO
$1.73B
– –
-2,673
Closed -$124K –
AIFU
87
AIFU Inc
AIFU
$69.3M
– –
-103
Closed -$516K –
SRGA
88
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
– –
-2,114
Closed -$289K –

Similar funds

Gagnon Securities's Q4 2017 Portfolio in Review

As of Q4 2017, Gagnon Securities held 102 positions worth $282M, up 4.8% from $269M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Gagnon Securities's Q4 2017 filing shows 7 new, 30 increased, 38 reduced and 11 closed positions. Its largest new stake was General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C: 35,792 shares worth $3.59M. The largest sale was Rudolph Technologies Inc, an estimated $2.81M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Industrials and Healthcare.

  • Gagnon Securities's largest Q4 2017 buy was General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C: 35,792 shares worth $3.59M.
  • Gagnon Securities added most to Flexion Therapeutics, Inc. in Q4 2017, an estimated $4.76M increase.
  • Gagnon Securities's biggest Q4 2017 reduction was Rudolph Technologies Inc, cutting an estimated $2.81M.
  • Gagnon Securities fully exited AIFU Inc in Q4 2017, selling an estimated $516K.
  • Gagnon Securities's ten largest holdings make up 45% of its $282M portfolio in Q4 2017.
  • Gagnon Securities opened 7 new positions and closed 11 in Q4 2017.
  • Gagnon Securities's portfolio value rose 4.8% quarter-over-quarter to $282M.

Based on Gagnon Securities's 13F filing for Q4 2017, filed 13 Feb 2018.